TLIS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TLIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Talis Biomedical's purchase of property, plant, equipment for the three months ended in Jun. 2024 was $0.00 Mil. It means Talis Biomedical spent $0.00 Mil on purchasing property, plant, equipment. Talis Biomedical's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Jun. 2024 was $0.02Mil.
Compared with last quarter ($0.00 Mil in Mar. 2024 ), Talis Biomedical spent the same money on purchasing property, plant, equipment in Jun. 2024 ($0.00 Mil).
The historical data trend for Talis Biomedical's Purchase Of Property, Plant, Equipment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Talis Biomedical Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Purchase Of Property, Plant, Equipment | Get a 7-Day Free Trial | -0.58 | -8.20 | -2.87 | -1.62 | -0.49 |
Talis Biomedical Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Purchase Of Property, Plant, Equipment | Get a 7-Day Free Trial | -0.49 | -0.07 | 0.09 | - | - |
The amount used to purchase PPE.
Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Talis Biomedical's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.
Andrew A Lukowiak | officer: President, other: Chief Scientific Officer | 1639 WINDEMERE DRIVE, SAN MARCOS CA 92078 |
Heinrich Dreismann | director | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Rebecca Markovich | officer: Interim CFO | CARS.COM INC., 300 S. RIVERSIDE PLAZA, SUITE 1000, CHICAGO IL 60606 |
Raymond Cheong | director | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Felix Baker | director, 10 percent owner | BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014 |
Baker Bros. Advisors Lp | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Julian Baker | director, 10 percent owner | BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014 |
Baker Brothers Life Sciences Lp | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
L.p. 667, | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Brian J Blaser | director, officer: President and CEO | 561 CIRCLE LANE, LAKE FOREST IL 60045 |
Ramesh Ramakrishnan | officer: Sr. Vice President, R&D | 230 CONSTITUTION DRIVE, MENLO PARK CA 94025 |
Randal W Scott | director | 171 MAIN STREET #225, LOS ALTOS CA 94022 |
Jeryl L Hilleman | director | C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025 |
Kimberly J Popovits | director | 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063 |
Moody John Roger Jr | officer: Chief Financial Officer | 4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 07-09-2022
By Marketwired • 04-27-2024
By sperokesalga sperokesalga • 05-11-2023
By GuruFocus Research • 02-09-2024
By Value_Insider Value_Insider • 11-03-2022
By Marketwired • 08-03-2023
By sperokesalga sperokesalga • 03-22-2023
By GuruFocus Research • 02-09-2024
By Marketwired • 07-24-2023
By GuruFocusNews GuruFocusNews • 06-29-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.